Loading
Defence Therapeutics Inc. Stock: price and insider trades · Canada
CA·Mcap CA$30.3M
Defence Therapeutics Inc.: what insiders have been doing
This page follows insider dealings at Defence Therapeutics Inc. as filed with SEDI. The last twelve months, up to 18 October 2026, brought 10 filings signed by 5 insiders.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Insider buying of Defence Therapeutics Inc. has been absent for the past year. The median gap between a trade and its publication by SEDI is 6 days. That lag is the time during which only the insider knows about the trade.
Across the 2,133 companies tracked on its exchange, the median is 12 filings; at 10 filings, this issuer sits below that mark.
This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Insider Decl.
10
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2024FY ended June 2024 · cache
CA$0.40
Analyst consensus
Income statement
EBITDA-CA$12.7M
Net income-CA$13.2M0.0% margin
Valuation
P/Book5.6x
Beta1.51
Balance sheet & cash
Market capCA$30.3M
Total debtCA$1.7M
Free Cash Flow-CA$4.5M
Debt / Equity29%
Profitability & ownership
ROE-232.8%
ROA-40.1%
% insiders12.8%
% institutions0.0%
Last declaration on 1 October 2026
Declarations10 total
3,500,000 sharesRestricted Stock UnitsTSXSEDI:4784227
Restricted Stock UnitsTSXSEDI:4784218
400,000 sharesOptionsTSXSEDI:4783324
OptionsTSXSEDI:4783322
3,500,000 sharesRights Restricted share unitsTSXSEDI:4782835
200,000 sharesOptionsTSXSEDI:4760380
200,000 sharesOptionsTSXSEDI:4759615
150,000 shares@ CA$0.60100.0% of flowOptionsTSXSEDI:4734769
OptionsTSXSEDI:4734749
OptionsTSXSEDI:4732784
10 of 10 declarations
About Defence Therapeutics Inc.
Defence Therapeutics Inc. is a company focused on developing innovative therapies for cancer treatment and other diseases. It is listed on the Toronto Stock Exchange under the symbol XTSE.
